This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
![](https://aptar.com/wp-content/uploads/2020/07/ONDD_April2018.jpg)
A track record of success for nasal drug delivery in drug repurposing
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions
![](https://aptar.com/wp-content/uploads/2020/07/Thumbnail_Webinar_N2B-1024x665.jpg)
The Nasal Drug Delivery Journey: from Systemic to Nose-to-Brain?
Webinars, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Device Innovations
![](https://aptar.com/wp-content/uploads/2022/04/AptarPharmaScientificPublications_Icon.jpg)
Using multi-dose nasal spray pumps for intranasal drug delivery
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations